# US 2017/0290542 A1 · Pathologic assessment of lower esophageal sphincter damage

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0290542 A1
- Document ID: US20170290542A1
- Status: Published application
- Kind: A1
- Application number: 15/481,225
- Filed: 2017-04-06
- Published: 2017-10-12
- Earliest claimed: 2016-04-08
- Inventors: PARAKRAMA CHANDRASOMA
- Web page: https://patentgrep.com/patent/US20170290542A1

## CPC

- A61B 5/4233: {oesophagus}
- A61B 1/233: for the nose, i.e. nasoscopes {, e.g. testing of patency of Eustachian tubes}
- A61B 5/0066: {Optical coherence imaging}
- A61B 5/0084: {for introduction into the body, e.g. by catheters (A61B5/1459 takes precedence)}
- A61B 5/6852: {Catheters}
- A61B 10/0283: {with vacuum aspiration, e.g. caused by retractable plunger or by connected syringe (A61B10/025, A61B10/0266 take precedence)}
- A61B 10/04: Endoscopic instruments, e.g. catheter-type instruments
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Determining the progression of reflux disease in the esophagus of a patient includes identifying the location of an endoscopic gastroesophageal junction in the esophagus, removing a length of tissue of the esophagus that includes a portion of the endoscopic gastroesophageal junction, and identifying the proximal limit of tissue containing cardiac epithelium. Determining the length of the squamo-oxyntic gap of the biopsied tissue can involve measuring the length of tissue extending between the proximal limit of tissue containing gastric oxyntic epithelium to the proximal limit of tissue containing cardiac epithelium. A linear relationship can be determined from a slope of a line extending between a first data point and a second data point that can determine a target age of the patient when the lower esophageal sphincter will have a certain length.

## Claims

### Claim at position 1

1-105. (canceled)

### Claim 106

A method of determining the progression of reflux disease in an esophagus of a patient, the method comprising:
identifying the location of an endoscopic gastroesophageal junction in the esophagus;
removing a length of tissue of the esophagus, wherein the length of tissue includes a portion of the endoscopic gastroesophageal junction, using a device comprising:
a cannula having a proximal end, a distal end, and a wall extending between the proximal and distal ends, and a lumen extending from a proximal region near the proximal end towards a distal region near the distal end,
an opening in the wall in the distal region, wherein the opening is in fluid communication with the lumen,
a connector in fluid communication with the lumen at the proximal region, wherein the connector is adapted to be connected to a vacuum source, and
a cutting member positioned near the opening and movable with respect to the opening;
identifying, using the length of tissue, the proximal limit of tissue containing cardiac epithelium;
determining the length of the squamo-oxyntic gap of a biopsied tissue by measuring the length of tissue extending between the proximal limit of tissue containing gastric oxyntic epithelium to the proximal limit of tissue containing cardiac epithelium;
determining a linear relationship comprising a slope of a line extending between a first data point and a second data point:
wherein the first data point corresponds to a first lower esophageal sphincter length and a first age, and
wherein the second data point corresponds to a second lower esophageal sphincter length and an age of the patient; and
determining a target age of the patient when the lower esophageal sphincter will have a length less than or equal to 10 mm using the linear relationship.

### Claim 107 (depends on 106)

The method of claim 106, wherein a length of the length of tissue is in the range of 5 mm to 30 mm or wherein a width of the length of tissue is in the range of 2 mm to 3 mm or wherein a thickness of the length of tissue is in the range of 1 mm to 2 mm.

### Claim 108 (depends on 106)

The method of claim 106, wherein the first data point corresponds to a lower esophageal sphincter length of 35 mm at the age of 10 if the patient has a history of childhood obesity, or a lower esophageal sphincter length of 35 mm at the age of 15 if the patient does not have a history of childhood obesity.

### Claim 109 (depends on 106)

The method of claim 106, wherein identifying the endoscopic gastroesophageal junction comprises using any one of an endoscope, trans-nasal endoscope, and optical coherence tomography.

### Claim 110 (depends on 106)

The method of claim 106, wherein determining the length of the squamo-oxyntic gap comprises using chromo-endoscopy.

### Claim 111 (depends on 106)

The method of claim 106 wherein the first lower esophageal sphincter length is 35 mm and the second lower esophageal sphincter length is the difference of 35 mm and the length of the squamo-oxyntic gap.

### Claim 112 (depends on 106)

The method of claim 106, further comprising a biopsy portion removably attached to the cannula, wherein the biopsy portion comprises the distal region.

### Claim 113 (depends on 112)

The method of claim 112 wherein the biopsy portion includes a proximal attachment portion and the cannula is configured to receive the proximal attachment portion of the biopsy portion.

### Claim 114 (depends on 113)

The method of claim 113 wherein the proximal attachment portion is secured using an external thread or a removable pin configured to secure the biopsy portion to the cannula.

### Claim 115 (depends on 112)

The method of claim 112 further including an o-ring configured to form a seal between the biopsy portion and the distal end of the cannula.

### Claim 116 (depends on 106)

The method of claim 106, wherein the distal region has any one of a c-shaped cross-section and an omega-shaped cross-section.

### Claim 117 (depends on 106)

The method of claim 106 further comprising the vacuum.

### Claim 118 (depends on 106)

The method of claim 106, wherein the cutting member comprises a blade or a wire that is any one of rectangular, cylindrical, and semi-cylindrical shapes.

### Claim 119 (depends on 106)

The method of claim 106, further comprising an actuator or a wire coupled to the cutting member, wherein the actuator or wire is configured to move axially within the distal region or axially adjacent to an outer surface of the distal region.

### Claim 120 (depends on 106)

The method of claim 106, wherein the cutting member is tubular with a circular cutting edge or tubular with an opening that is aligned about the opening of the extraction structure, the cutting member configured to cut tissue extending within the opening of the extraction structure.

### Claim 121 (depends on 120)

The method of claim 120, wherein the opening has a length along an axial length of the cannula of between 10 mm to 35 mm and/or a width along a circumferential direction of the cannula of between and including 1 mm-2 mm, 2 mm-3 mm, 3 mm-4 mm, 4 mm-5 mm, 5 mm-6 mm, 6 mm-7 mm, 7 mm-8 mm, 8 mm-9 mm, and 9 mm-10 mm.

### Claim 122 (depends on 106)

The method of claim 106, wherein the cutting member includes a plurality of blades wherein the plurality of blades are located along opposite sides of the opening and wherein the cutting member is configured rotate circumferentially with respect to the opening.

### Claim 123

A method of determining the progression of reflux disease in an esophagus of a patient, the method comprising:
identifying the location of an endoscopic gastroesophageal junction in the esophagus;
removing a length of tissue of the esophagus, wherein the length of tissue includes a portion of the endoscopic gastroesophageal junction;
identifying, using the length of tissue, the proximal limit of tissue containing cardiac epithelium;
determining the length of the squamo-oxyntic gap of a biopsied tissue by measuring the length of tissue extending between the proximal limit of tissue containing gastric oxyntic epithelium to the proximal limit of tissue containing cardiac epithelium; and
determining a target age of the patient when the lower esophageal sphincter will have a length less than or equal to 10 mm,
wherein the target age is based on a relationship between a first data point and a second data point,
wherein the first data point corresponds to a first lower esophageal sphincter length and a first age, and
wherein the second data point corresponds to a second lower esophageal sphincter length and an age of the patient.

### Claim 124 (depends on 123)

The method of claim 123, wherein the first data point corresponds to a lower esophageal sphincter length of 35 mm at the age of 10 if the patient has a history of childhood obesity, or a lower esophageal sphincter length of 35 mm at the age of 15 if the patient does not have a history of childhood obesity.

### Claim 125 (depends on 123)

The method of claim 123 wherein the first lower esophageal sphincter length is 35 mm and the second lower esophageal sphincter length is the difference of 35 mm and the length of the squamo-oxyntic gap.
